摩熵新药早报 | 华东医药前三季度营收314亿,净利润增长17%,重仓GLP-1!三生制药、宜联生物、翰森制药等出现重要进展

药融云新药笔记
Oct 26, 2024

1.华东医药2024Q3财报:前三季度营收314亿,净利润增长17%,重仓GLP-110月24日晚,华东医药发布第三季度报告,报告期内,公司合计实现营业收入314.78亿元,同比增长3.56%;实现归属于上市公司股东的净利润25.62亿元,同比增长17.05%。其中第三季度华东医药实现营业收入105.13亿元,同比增长5.03%;实现归属于上市公司股东的净利润8.66亿元,同比增长14.71%。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10